HES 130/0.4 (Voluven®) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial

Thomas Standl, H. Lochbuehler, C. Galli, Adam Reich, G. Dietrich, H. Hagemann

European Journal of Anaesthesiology · 2008 · 64 citations · 37 references

Abstract

Both HES 130/0.4 and human albumin 5% were effective for haemodynamic stabilization in non-cardiac surgery of young infants with no adverse impact on coagulation or other safety parameters in our study population.

References

37